Anton Dobrin
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Immunology top 2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Papers in
- Oncology 14
- CAR-T cell therapy research 10
- Cancer Immunotherapy and Biomarkers 4
-
- T-cell and B-cell Immunology 1
- Immunotherapy and Immune Responses 1
- Co-authors
- Michel Sadelain (7 shared papers)Zeguo Zhao (5 shared papers)Mohamad Hamieh (3 shared papers)Justin Eyquem (2 shared papers)Annalisa Cabriolu (2 shared papers)Judith Feucht (2 shared papers)Josef Leibold (1 shared paper)Yu-Jui Ho (1 shared paper)
- Journals
- Nature (5 papers)Nature Medicine (2 papers)Science Immunology (1 paper)Integrative Biology (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Anton Dobrin
14 papers receiving 2.7k citations
Anton Dobrin's Hit Papers
Peers
Comparison fields: 5 of 70
- Oncology 1.8k
- Immunology 766
- Molecular Biology 397
- Physiology 17
- Cancer Research 56
Countries citing papers authored by Anton Dobrin
This map shows the geographic impact of Anton Dobrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Dobrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Dobrin more than expected).
Fields of papers citing papers by Anton Dobrin
This network shows the impact of papers produced by Anton Dobrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Dobrin. The network helps show where Anton Dobrin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anton Dobrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer Hit paper breakdown → | 2023 | 1009 |
| 2 | CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape Hit paper breakdown → | 2019 | 545 |
| 3 | 2018 | 448 | |
| 4 | 2022 | 157 | |
| 5 | 2022 | 154 | |
| 6 | 2023 | 119 | |
| 7 | 2022 | 85 | |
| 8 | 2023 | 70 | |
| 9 | 2024 | 57 | |
| 10 | 2017 | 39 | |
| 11 | 2015 | 19 | |
| 12 | 2025 | 16 | |
| 13 | 2024 | 12 | |
| 14 | 2025 | 1 | |
| 15 | 2026 | 0 |
About Anton Dobrin
Anton Dobrin is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Nuclear Energy and Engineering, having authored 15 papers that have together received 2.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Cancer Immunotherapy and Biomarkers (4 papers), T-cell and B-cell Immunology (1 paper), Gene Regulatory Network Analysis (1 paper), Cancer Genomics and Diagnostics (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (1.8k citations), Immunology (766 citations), Molecular Biology (397 citations), Physiology (17 citations) and Cancer Research (56 citations). Anton Dobrin has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Michel Sadelain, Zeguo Zhao, Mohamad Hamieh, Justin Eyquem, Annalisa Cabriolu, Judith Feucht, Josef Leibold, Yu-Jui Ho, Jie Sun and Jorge Mansilla‐Soto. Their work appears in journals such as Nature, Nature Medicine, Science Immunology, Integrative Biology and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.